of situation imposes difficult scenario and put labs in a dilemma whether to use plastic tubes in place of glass tubes. Also the literature is extremely sparse in reference to the use of plastic tubes and shows inconsistence results. Hence, there is a need for further studies. To handle this scenario of the recall, the quality assurance project was performed at CMC Philadelphia VA Medical Center. Method: We collected 65 venous blood samples into 4.5 mL glass tubes and 2.7 mL plastic tubes from mix population patients with and without anticoagulant therapy. After centrifugation we used Diagnostic Stago instrument with Stago reagents for this testing. Mean and standard deviation (SD) were used to verify the adequacy of the analytic ranges in the study and to summarize results. Results: In our results, there was no statistically significance difference observed in prothrombin time, activated partial thromboplastin time, and fibrinogen results. We used Bland-Altman plot for determination of results comparison. Bland-Altman plot shows good correlation between two methods, and their regression shows excellent correlation of r values between 0.98 and 1.00. There is no indication of bias between the methods. Conclusion: Our study shows that the plastic tubes can be safely and successfully used for the coagulation studies in place of glass tubes. 
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Objectives:
We have previously examined the effect of crizotonib (criz) and doxorubicin (dox) on cell lines of ALK+ anaplastic large cell lymphoma (ALCL), and found that while criz induces apoptosis, the effect is antagonized by dox. We also found that criz-induced apoptosis was associated with downregulation of the cell cycle check point modulator CDK2, which is required for transition from G1 into S phase. The current experiment examined cell cycle effects of the two drugs on the ALK+ ALCL cell line Karpas 299 (K299). Methods: K299 cells were incubated with slightly less than IC50 doses of each drug, alone and in combination, and compared to untreated controls. The cells were collected after six hours, suspended with PI/RNase staining solution, and acquired using a BD LSRFortessa (BD Biosciences, San Jose, CA) cell analyzer. Cell cycle analysis data were generated using FCS Express, version 5 (DeNovo Software, Los Angeles, CA) with the MultiCycle AV DNA analysis package.
Results: Criz showed marked decrease in S phase with increase in G1 phase compared to untreated cells, whereas both dox alone and in combination with criz showed mild increase in S phase with decrease in G1 phase compared to untreated cells. Conclusion: Results show that criz inhibits progression through cell cycle, while dox-treated cells progress through cell cycle. Cells treated with both drugs behave similarly to those with dox alone. These findings are consistent with doxorubicin antagonism of crizotinib at the level of the cell cycle in ALK+ ALCL Northshore University Healthsystem, Evanston, IL Objectives: To determine the association between tumor grade with mortality and venous thromboembolism (VTE) in patients with gastric cancer (GC). Methods: Single institution cohort of GC treated patients (2010) (2011) (2012) (2013) (2014) (2015) . VTE events were objectively confirmed. Active GC was defined as biopsy-proven metastatic disease or on active chemotherapy. We defined stage as limited (Stage I-II) and advanced (stage III-IV). We used the four-level grading system of the American Joint Committee on Cancer to stratified adenocarcinoma (G1-G4). We stratified gastrointestinal stromal tumor into low and high grade based on their mitotic rate. To make twolevel and four-level grading systems comparable, adenocarcinoma was stratified into low (G1 and G2) and high (G3 and G4) grade. Continuous and categorical data are expressed by the median (interquartile range) and by percentages. We used SPSS version 23 to estimate the association of tumor grade with VTE and mortality using Cox proportional regression. Results: We included 106 patients who were predominantly men (64%), with a median age of 59 (52-65) years, adenocarcinoma (85%), and advanced disease (58%). The median follow-up was 22.6 months (9.8-42.6). The cumulative incidence of VTE at one year was 13%. The median time from diagnosis to VTE occurrence was 59 days (36-258). Tumor grade was not associated with a higher risk of VTE (univariate HR 0.60; 95% CI 0.19-1.84; P = .37) or mortality (univariate HR 1.09; 95% CI 0.64-1.86; P = .74). In multivariate analysis, after adjusting for BMI, stage, performance status, only obesity (HR 4.11; 95% CI 1.74-13.31; P = .18) and performance
